CYPH Cypherpunk Technologies Inc. Common Stock
XNAS
2.95
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $0.49 – $4.19
- YTD
- +161.06%
- IV Rank (30D)
- 10.51
- Straddle Price
- $1.25
- P/C Vol Ratio
- 1.17
- Market Cap
- $0.4B
- Open
- $2.94
- Day Range
- $2.93 – $3.28
- Volume
- 8,250,604
- Prev Close
- $3.33
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.15% |
| Beta vs SPY | 1.19 |
| Cost of Equity (CAPM) | 11.71% (VRP-adj) |
| WACC | 10.85% |
| Volatility Risk Premium | +14.2pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +3.0% |
| DCF Horizon | 5 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.03 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $-0.0B |
| Return on Equity (TTM) | -0.6% |
| Book / Price | 28.6% |
| Debt / Equity | 0.00 |
| Quality Score | 1/6 — cyclical/struggling (5y DCF) |
| SMA 50 | $2.43 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $3.09 |
| Bollinger Width / SMA20 | 1718.6% (drives anchor stability) |
| Net Debt | $-0.0B |
| Market Cap | $0B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | n/a | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | median 25.9× · 3 peers |
| Peer EV/EBITDA | n/a | 0% | median 14.7× · 3 peers |
| Peer P/B | $2.97 | 21% | median 3.1× · 4 peers |
| Peer P/S | n/a | 0% | median 2.6× · 3 peers |
| Market Anchor (SMA50) | $2.43 | 79% | stability 74% (BB-width) |
| Options Expected (B-L 30d) | $2.80 | 0% | 9 strikes · skew +0.99 |
- Industry (SIC)
- PHARMACEUTICAL PREPARATIONS (2834) · industry map
- Exchange
- XNAS
- Market Cap
- $0.4B
- Employees
- 6
- List Date
- 2014-07-31
- CIK
- 0001509745
- Next Earnings
- 2026-11-11 (Pre-Market)
- Headquarters
- Cambridge, MA
- Homepage
- https://www.cypherpunk.com
Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related pr…
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '25 | '26 | Avg |
|---|---|---|---|
| Jan | -- | -34.04% | -34.04% |
| Feb | -- | -18.20% | -18.20% |
| Mar | -- | 22.11% | 22.11% |
| Apr | -- | 15.53% | 15.53% |
| May | -- | 16.10% | 16.10% |
| Jun | -- | -41.69% | -41.69% |
| Jul | -- | -8.56% | -8.56% |
| Aug | -- | 186.59% | 186.59% |
| Sep | -- | 94.74% | 94.74% |
| Oct | -- | 0.34%* | 0.34% |
| Nov | -13.07% | -- | -13.07% |
| Dec | -5.69% | -- | -5.69% |
| Total | -18.02% | 163.86% | 72.92% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report
Executive Summary BULLISH (confidence level: 6/10)
Key drivers: Technical indicators, momentum oscillators, and recent options activity.
Primary risks: High volatility, mixed signals from technical indicators, and potential for a breakout or breakdown.
Investment thesis: CYPH is poised to break out of its current range, driven by bullish momentum signals and recent options activity. However, high volatility and mixed technical signals pose risks that need to be managed.
Recent news sentiment impact: No recent news available, which reduces the influence on short-term price action.
Technical Analysis Trend Direction: Short-term (1-4 weeks): Range-bound Medium-term (1-3 months): Uptrend Long-term (3-12 months): N/A
Support/Resistance Levels:
- Upper band: $0.75
- Middle line: $0.66
- Lower band: $0.58
Momentum Signals: RSI interpretation: Neutral (44.89) MACD signal: Bearish (negative histogram) Bollinger Bands position: Squeeze
Volume Analysis: Volume SMA 20: 1158294.20 On-Balance Volume (OBV): 180504351.41 Volume Rate of Change: -27.64%
News & Sentiment Analysis Recent Headlines Summary: No recent news available.
Sentiment Assessment: Neutral (no recent news)
Catalyst Identification: None
Market Narrative: The lack of recent news reduces the influence on short-term price action, allowing technical signals to take center stage.
Risk & Volatility Assessment Beta Interpretation: High risk relative to market (beta > 1.5)
Volatility Regime: Current volatility is higher than historical levels.
Options Market Signals: IV Rank: 59.3% (Medium) Current IV: 359.5% Expected Move: $0.20 (35 DTE), 7-DTE: $0.20 Volume Flow: 26 calls vs 235 puts Open Interest: 10,132 calls vs 2,006 puts Put/Call Volume Ratio: 9.04 (Bearish sentiment) Put/Call OI Ratio: 0.20
Downside Protection: Support levels and risk management considerations are crucial due to the high volatility and mixed technical signals.
Market Context & Positioning Sector Performance: N/A
Institutional Activity: Mixed volume patterns suggesting institutional interest is moderate.
Correlation Analysis: CYPH is highly correlated with the market (R-squared interpretation).
Relative Valuation: Position within trading range.
Key Levels & Action Items Critical Price Levels:
- Upper band: $0.75
- Middle line: $0.66
- Lower band: $0.58
Breakout/Breakdown Levels: Any move above/below the upper/lower bands could trigger significant price action.
Time-Sensitive Catalysts: Earnings dates, product launches, and regulatory changes.
Risk Management: Stop-loss levels and position sizing considerations are crucial due to high volatility and mixed technical signals.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2026-03-16 | Pre-Market | 21.55% | 21.53% | 1.00x | Within |
| 2026-05-12 | Pre-Market | 20.45% | 2.73% | 0.13x | Within |
| 2026-08-13 | Pre-Market | 26.60% | 1.50% | 0.06x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
CYPH Options Activity & IV Rank
CYPH IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Options Flow
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Estimated net dealer gamma is at the 95th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 235
Period: 252 trading days
High volatility - stock moves more than market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Citadel Hedge fund Ken Griffin | $512K | #4441 of 6285 | new | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
CYPH Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $355.75K | 38.09% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $259.00K | 27.73% | 2026-06-30 |
| 3 | Simplex Trading, LLC Custodian | $110.59K | 11.84% | 2026-06-30 |
| 4 | Jane Street Group, LLC Custodian | $107.83K | 11.54% | 2026-06-30 |
| 5 | GROUP ONE TRADING LLC Custodian | $94.17K | 10.08% | 2026-06-30 |
| 6 | Key Client Fiduciary Advisors, LLC | $6.74K | 0.72% | 2026-06-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $123.22K | 52.27% | 2026-06-30 |
| 2 | Jane Street Group, LLC Custodian | $53.64K | 22.75% | 2026-06-30 |
| 3 | GROUP ONE TRADING LLC Custodian | $25.41K | 10.78% | 2026-06-30 |
| 4 | Simplex Trading, LLC Custodian | $16.77K | 7.11% | 2026-06-30 |
| 5 | Citadel Advisors LLC Custodian | $16.72K | 7.09% | 2026-06-30 |
CYPH Insider Trading (Form 4)
Latest: 2026-10-14| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-14 | William Patrick McEvoy III | Chief Investment Officer | Exer (X) | +4,938,801 | $0.00 | $4.9K | EDGAR |
| 2026-10-14 | Winklevoss Treasury Investments, LLC | 10%+ Owner | Exer (X) | +24,694,005 | $0.00 | $24.7K | EDGAR |
| 2026-09-25 | Patricia A. Martin | Director | Sell (S) | −50,000 | $3.86 | -$193.0K | EDGAR |
| 2026-09-25 | Khing Djien Oei | Director | Sell (S) | −168,750 | $3.92 | -$661.5K | EDGAR |
| 2026-08-27 | Thomas John Dietz | Director | Sell (S) | −20,000 | $1.72 | -$34.4K | EDGAR |
| 2026-08-24 | Kevin Zhang | Head of Mining | Grant (A) | −2,000,000 RSU | — | EDGAR | |
| 2026-08-19 | William Patrick McEvoy III | Chief Investment Officer | Exer (X) | +16,570,852 | $0.00 | $16.6K | EDGAR |
| 2026-08-19 | Winklevoss Capital Fund, LLC | 10%+ Owner | Exer (X) | +82,854,260 | $0.00 | $82.9K | EDGAR |
| 2026-07-02 | Douglas E Onsi | CEO,CFO,Pres.,GC,Treas.&Sec. | Grant (A) | −1,000,000 RSU | — | EDGAR | |
| 2026-07-02 | William Li | Director | Grant (A) | −75,000 RSU | — | EDGAR | |
| 2026-07-02 | Christian M Richard | Director | Grant (A) | −75,000 RSU | — | EDGAR | |
| 2026-07-02 | Nissim Mashiach | Director | Grant (A) | −75,000 RSU | — | EDGAR | |
| 2026-07-02 | William Patrick McEvoy III | Chief Investment Officer | Grant (A) | −1,000,000 RSU | — | EDGAR | |
| 2026-07-02 | Khing Djien Oei | Director | Grant (A) | −100,000 RSU | — | EDGAR | |
| 2026-07-02 | Patricia A. Martin | Director | Grant (A) | −75,000 RSU | — | EDGAR |
CYPH Insider Holdings
13 insiders · @ $2.95| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | William Patrick McEvoy III | Chief Investment Officer | 29,793,414 | $87.89M | $0 | 4 | 2026-10-14 |
| 2 | Winklevoss Treasury Investments, LLC | 10%+ Owner | 29,793,414 | $87.89M | $0 | 2 | 2026-10-14 |
| 3 | Winklevoss Capital Fund, LLC | 10%+ Owner | 24,854,613 | $73.32M | $0 | 1 | 2026-08-19 |
| 4 | James H Cavanaugh | Director | 168,963 | $498.4K | -$822.2K | 3 | 2026-03-17 |
| 5 | William Li | Director | 168,750 | $497.8K | $0 | 3 | 2026-07-02 |
| 6 | Nissim Mashiach | Director | 168,750 | $497.8K | $0 | 3 | 2026-07-02 |
| 7 | Thomas John Dietz | Director | 132,500 | $390.9K | -$34.4K | 4 | 2026-08-27 |
| 8 | Christopher Mirabelli | Director | 130,376 | $384.6K | -$2.17M | 4 | 2026-03-30 |
| 9 | Patricia A. Martin | Director | 118,750 | $350.3K | -$193.0K | 4 | 2026-09-25 |
| 10 | Douglas E Onsi | CEO,CFO,Pres.,GC,Treas.&Sec. | 106,858 | $315.2K | -$2.12M | 3 | 2026-07-02 |
CYPH Board & Officers
As of SEC filings through Oct 14, 2026Directors 9
- Thomas John Dietz · since Jan 20, 2017
- Nissim Mashiach · since Jan 23, 2017
- William Li · since Jan 23, 2017
- Douglas E Onsi · listed since Mar 2020
- Christian M Richard · since Jan 17, 2023
- Patricia A. Martin · since Jan 17, 2023
- Khing Djien Oei · since Nov 11, 2025
- William Patrick McEvoy III · since Nov 11, 2025
- Amanda Fabiano · since Sep 21, 2026
Officers 3
- Douglas E Onsi · CEO,CFO,Pres.,GC,Treas.,&Sec. · listed since Jan 2021
- William Patrick McEvoy III · Chief Investment Officer · since Nov 11, 2025
- Kevin Zhang · Head of Mining · since Aug 18, 2026
10% owners 6
- Cameron Howard Winklevoss · since Oct 8, 2025
- Tyler Howard Winklevoss · since Oct 8, 2025
- William Patrick McEvoy III · since Nov 11, 2025
- Winklevoss Capital Fund, LLC (entity) · since Oct 8, 2025
- Winklevoss Capital Management, LLC (entity) · since Oct 8, 2025
- Winklevoss Treasury Investments, LLC (entity) · since Oct 8, 2025
Changes in the last 10 years (77)
| Sep 21, 2026 | Amanda Fabiano became a director |
| Aug 18, 2026 | Kevin Zhang became Head of Mining |
| Apr 7, 2026 | The company announced the departure of Richard Schilsky from the board in an SEC filing |
| Apr 7, 2026 | The company announced the departure of Joseph Loscalzo from the board in an SEC filing |
| Apr 7, 2026 | The company announced the departure of James H Cavanaugh from the board in an SEC filing |
| Apr 7, 2026 | The company announced the departure of Christopher Mirabelli from the board in an SEC filing |
| Nov 13, 2025 | Christopher Mirabelli no longer listed as Chairman of the Board in SEC filings |
| Nov 11, 2025 | William Patrick McEvoy III became a director |
| Nov 11, 2025 | William Patrick McEvoy III became a 10% owner |
| Nov 11, 2025 | William Patrick McEvoy III became Chief Investment Officer |
| Nov 11, 2025 | Khing Djien Oei became a director |
| Oct 8, 2025 | Winklevoss Treasury Investments, LLC became a 10% owner |
| Oct 8, 2025 | Winklevoss Capital Management, LLC became a 10% owner |
| Oct 8, 2025 | Winklevoss Capital Fund, LLC became a 10% owner |
| Oct 8, 2025 | Tyler Howard Winklevoss became a 10% owner |
| Oct 8, 2025 | Cameron Howard Winklevoss became a 10% owner |
| Jun 30, 2025 | John Mark O'Mahony left as Chief Manufacturing Officer, per their own SEC filing |
| Jun 30, 2025 | Jason Baum left as Chief Scientific Officer, per their own SEC filing |
| Jun 30, 2025 | Augustine Lawlor left as Chief Operating Officer, per their own SEC filing |
| Apr 10, 2024 | Gilead Sciences, Inc. became a 10% owner |
| Aug 25, 2023 | Christopher Mirabelli first listed as Chairman of the Board in an SEC filing |
| Apr 1, 2023 | Jason Baum became Chief Scientific Officer |
| Jan 17, 2023 | Patricia A. Martin became a director |
| Jan 17, 2023 | Christian M Richard became a director |
| Sep 2, 2022 | Douglas E Onsi no longer listed as a 10% owner in SEC filings |
| Sep 2, 2022 | Cynthia Sirard no longer listed as a 10% owner in SEC filings |
| Sep 2, 2022 | Augustine Lawlor no longer listed as a 10% owner in SEC filings |
| Sep 1, 2022 | Richard Schilsky became a director |
| Aug 11, 2022 | The company announced the departure of Monica Bertagnolli from the board in an SEC filing |
| Feb 2, 2022 | Cynthia Sirard first listed as a 10% owner in an SEC filing |
| Feb 2, 2022 | Christopher Mirabelli no longer listed as a 10% owner in SEC filings |
| Sep 28, 2021 | Perceptive Life Sciences Master Fund Ltd reported in an SEC filing no longer being a 10% owner |
| Sep 28, 2021 | Perceptive Advisors LLC reported in an SEC filing no longer being a 10% owner |
| Sep 28, 2021 | Joseph Edelman reported in an SEC filing no longer being a 10% owner |
| Feb 11, 2021 | Healthcare Partners IX, LLC reported in an SEC filing no longer being a 10% owner |
| Feb 11, 2021 | Healthcare Partners IX, L.P. reported in an SEC filing no longer being a 10% owner |
| Feb 11, 2021 | HealthCare Ventures IX, L.P. reported in an SEC filing no longer being a 10% owner |
| Jan 28, 2021 | Douglas E Onsi listed as CEO,CFO,Pres.,GC,Treas.,&Sec. (previously CFO, GC, Treasurer & Secretary) in SEC filings |
| Jan 28, 2021 | Christopher Mirabelli no longer listed as CEO, President, COB in SEC filings |
| Jan 6, 2021 | James H Cavanaugh no longer listed as a 10% owner in SEC filings |
| Dec 30, 2020 | HealthCare Ventures VIII, L.P. reported in an SEC filing no longer being a 10% owner |
| Dec 30, 2020 | HealthCare Partners VIII, LLC reported in an SEC filing no longer being a 10% owner |
| Dec 30, 2020 | HealthCare Partners VIII, L.P. reported in an SEC filing no longer being a 10% owner |
| Aug 16, 2020 | Christine Granfield became VP, Head of Reg Affairs/Qual |
| Apr 1, 2020 | John Mark O'Mahony became Chief Manufacturing Officer |
| Apr 1, 2020 | Cynthia Sirard became Chief Medical Officer |
| Mar 19, 2020 | Douglas E Onsi first listed as a director in an SEC filing |
| Mar 12, 2020 | BeiGene, Ltd. became a 10% owner |
| Mar 9, 2020 | Perceptive Life Sciences Master Fund Ltd became a 10% owner |
| Mar 9, 2020 | Perceptive Advisors LLC became a 10% owner |
| Mar 9, 2020 | Joseph Edelman became a 10% owner |
| Dec 5, 2018 | Monica Bertagnolli became a director |
| Nov 16, 2017 | Douglas E Onsi listed as CFO, GC, Treasurer & Secretary (previously CFO,Gen Counsel,Treas, Sec.) in SEC filings |
| Nov 16, 2017 | Christopher Mirabelli listed as CEO, President, COB (previously CEO,Pres,Chairman of the Board) in SEC filings |
| Nov 14, 2017 | LILLY ELI & CO became a 10% owner |
| Jan 23, 2017 | William Li became a director |
| Jan 23, 2017 | Nissim Mashiach became a director |
| Jan 20, 2017 | Thomas John Dietz became a director |
| Jan 20, 2017 | Joseph Loscalzo became a director |
| Jan 20, 2017 | John W Littlechild became a director |
| Jan 20, 2017 | John W Littlechild became a 10% owner |
| Jan 20, 2017 | James H Cavanaugh became a director |
| Jan 20, 2017 | James H Cavanaugh became a 10% owner |
| Jan 20, 2017 | Healthcare Partners IX, LLC became a 10% owner |
| Jan 20, 2017 | Healthcare Partners IX, L.P. became a 10% owner |
| Jan 20, 2017 | HealthCare Ventures VIII, L.P. became a 10% owner |
| Jan 20, 2017 | HealthCare Ventures IX, L.P. became a 10% owner |
| Jan 20, 2017 | HealthCare Partners VIII, LLC became a 10% owner |
| Jan 20, 2017 | HealthCare Partners VIII, L.P. became a 10% owner |
| Jan 20, 2017 | Harold R Werner became a 10% owner |
| Jan 20, 2017 | Douglas E Onsi became a 10% owner |
| Jan 20, 2017 | Douglas E Onsi became CFO,Gen Counsel,Treas, Sec. |
| Jan 20, 2017 | Christopher Mirabelli became a director |
| Jan 20, 2017 | Christopher Mirabelli became a 10% owner |
| Jan 20, 2017 | Christopher Mirabelli became CEO,Pres,Chairman of the Board |
| Jan 20, 2017 | Augustine Lawlor became a 10% owner |
| Jan 20, 2017 | Augustine Lawlor became Chief Operating Officer |
- Prev
- 1
Not reported recently (7)
- Cynthia Sirard · Last reported as Chief Medical Officer in an SEC filing dated Apr 1, 2025
- Christine Granfield · Last reported as VP, Head of Reg Affairs/Qual in an SEC filing dated Apr 1, 2025
- Gilead Sciences, Inc. · Last reported as a 10% owner in an SEC filing dated Apr 19, 2024
- BeiGene, Ltd. · Last reported as a 10% owner in an SEC filing dated Sep 28, 2021
- John W Littlechild · Last reported as a director in an SEC filing dated Mar 4, 2020
- LILLY ELI & CO · Last reported as a 10% owner in an SEC filing dated Aug 13, 2018
- Harold R Werner · Last reported as a 10% owner in an SEC filing dated Aug 1, 2018
CYPH Proposed Insider Sales (Form 144)
Latest: 2026-08-26What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-08-26 | Dietz Thomas John | Director | 20,000 | $32.3K | 2026-08-26 | Charles Schwab Corporation | — | EDGAR |
| 2026-03-27 | CHRISTOPHER MIRABELLI | Director | 60,000 | $42.6K | 2026-03-26 | LPL Financial LLC | — | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $9.6M | — | 2026-09-30 |
| 2 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $3.3M | — | 2026-09-30 |
| 3 | SATO Invesco Alerian Galaxy Crypto Economy ETF | Invesco | 2.01% | $144,507 | — | 2026-10-20 |
| 4 | AVSC Avantis U.S. Small Cap Equity ETF | Avantis | 0.00% | $81,560 | $3.1B | 2026-10-20 |
| 5 | PINK Simplify Health Care ETF | Nport | 0.00% | $17,132 | — | 2026-06-30 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (3 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $0.00 | $39.39M | $0.18 | $-2.69M |
| Q1 '26 | 2026-03-31 | — | $-77.17M | $-0.46 | $-3.43M |
| Q4 '25 | 2025-12-31 | — | $40.20M | $0.92 | $-6.62M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.